These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 11309307)

  • 21. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.
    Brantley-Sieders DM; Fang WB; Hwang Y; Hicks D; Chen J
    Cancer Res; 2006 Nov; 66(21):10315-24. PubMed ID: 17079451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
    Nör JE; Christensen J; Liu J; Peters M; Mooney DJ; Strieter RM; Polverini PJ
    Cancer Res; 2001 Mar; 61(5):2183-8. PubMed ID: 11280784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway].
    Wang F; Tian YH; Li L; Chen XF; Hu HH; Li CY; Huang Q
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):165-70. PubMed ID: 12006990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis.
    Viloria-Petit A; Crombet T; Jothy S; Hicklin D; Bohlen P; Schlaeppi JM; Rak J; Kerbel RS
    Cancer Res; 2001 Jul; 61(13):5090-101. PubMed ID: 11431346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
    Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
    Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of angiogenesis and tumorigenicity of human melanocytic cells by vascular endothelial growth factor and basic fibroblast growth factor.
    Graeven U; Rodeck U; Karpinski S; Jost M; Philippou S; Schmiegel W
    Cancer Res; 2001 Oct; 61(19):7282-90. PubMed ID: 11585767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts.
    Oku T; Tjuvajev JG; Miyagawa T; Sasajima T; Joshi A; Joshi R; Finn R; Claffey KP; Blasberg RG
    Cancer Res; 1998 Sep; 58(18):4185-92. PubMed ID: 9751633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus-mediated wild-type p53 overexpression inhibits endothelial cell differentiation in vitro and angiogenesis in vivo.
    Riccioni T; Cirielli C; Wang X; Passaniti A; Capogrossi MC
    Gene Ther; 1998 Jun; 5(6):747-54. PubMed ID: 9747454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo.
    Bendrik C; Robertson J; Gauldie J; Dabrosin C
    Cancer Res; 2008 May; 68(9):3405-12. PubMed ID: 18451168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
    Ferrario A; von Tiehl KF; Rucker N; Schwarz MA; Gill PS; Gomer CJ
    Cancer Res; 2000 Aug; 60(15):4066-9. PubMed ID: 10945611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis.
    Yoshiji H; Kuriyama S; Ways DK; Yoshii J; Miyamoto Y; Kawata M; Ikenaka Y; Tsujinoue H; Nakatani T; Shibuya M; Fukui H
    Cancer Res; 1999 Sep; 59(17):4413-8. PubMed ID: 10485491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RB2/p130 gene-enhanced expression down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo.
    Claudio PP; Stiegler P; Howard CM; Bellan C; Minimo C; Tosi GM; Rak J; Kovatich A; De Fazio P; Micheli P; Caputi M; Leoncini L; Kerbel R; Giordano GG; Giordano A
    Cancer Res; 2001 Jan; 61(2):462-8. PubMed ID: 11212232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival.
    Chen Z; Varney ML; Backora MW; Cowan K; Solheim JC; Talmadge JE; Singh RK
    Cancer Res; 2005 Oct; 65(19):9004-11. PubMed ID: 16204074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.
    Rofstad EK; Halsør EF
    Cancer Res; 2000 Sep; 60(17):4932-8. PubMed ID: 10987309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
    Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
    Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells.
    Yoshiji H; Kuriyama S; Yoshii J; Yamazaki M; Kikukawa M; Tsujinoue H; Nakatani T; Fukui H
    Hepatology; 1998 Dec; 28(6):1489-96. PubMed ID: 9828211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of tumor angiogenesis by stem cell factor.
    Zhang W; Stoica G; Tasca SI; Kelly KA; Meininger CJ
    Cancer Res; 2000 Dec; 60(23):6757-62. PubMed ID: 11118063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
    Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
    J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FGF-3 and FGF-4 elicit distinct oncogenic properties in mouse mammary myoepithelial cells.
    Hajitou A; Baramova EN; Bajou K; Noë V; Bruyneel E; Mareel M; Collette J; Foidart JM; Calberg-Bacq CM
    Oncogene; 1998 Oct; 17(16):2059-71. PubMed ID: 9798677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells.
    Mattila MM; Ruohola JK; Valve EM; Tasanen MJ; Seppänen JA; Härkönen PL
    Oncogene; 2001 May; 20(22):2791-804. PubMed ID: 11420691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.